Standardized Indices of Breathlessness
标准化呼吸困难指数
基本信息
- 批准号:7158099
- 负责人:
- 金额:$ 46.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:breath testschronic obstructive pulmonary diseaseclinical researchcomputer assisted diagnosiscomputer program /softwarecomputer system design /evaluationdiagnosis design /evaluationdiagnosis quality /standarddyspneasfunctional abilityhuman subjectinterviewlongitudinal human studypatient oriented researchrespiratory airflow disorderrespiratory airflow measurementrespiratory disorder diagnosisself examinationspirometrystatistics /biometry
项目摘要
DESCRIPTION (provided by applicant): For patients with respiratory disease the symptom of breathlessness (dyspnea) is the most frequent reason for seeking medical attention. Current methods for measuring the impact of breathlessness on activities of daily living rely on face-to-face interviews conducted by health care providers. Two common measures are the Baseline Dyspnea Index representing the severity of dyspnea at a single point in time, and the Transition Dyspnea Index representing changes in dyspnea compared with the baseline level before treatment. Despite widespread acceptance of these measures, the interview technique has been criticized on three counts: (1) selection of severity of breathlessness is made by the interviewer, not the patient, and thereby can increase measurement error (2) the method cannot be applied consistently in different medical centers because the same interviewers are not employed at all test sites (3) the process is expensive due to the cost of training and employing health care providers to conduct interviews and enter data into the computer. There is a need for a less expensive, standardized approach to the measurement of dyspnea that could be applied consistently throughout the world. In Phase I of this project computerized versions of the Baseline Dyspnea Index and the Transitional Dyspnea Index were developed and tested for concurrent validity by comparison with interview versions, and for construct validity by comparison with pulmonary function tests. The aims of Phase II are to determine further psychometric and clinical properties of the standardized methods: test- retest reliability of both the Baseline and Transition Dyspnea Indices, responsiveness and the minimally important clinical difference of the Transition Dyspnea Index. Subjects employing the new, standardized computer methods will be 126 patients diagnosed with chronic lung disease. PROPOSED COMMERCIAL APPLICATIONS. There are excellent commercial prospects for computer software that allows the patient to rate their level of dyspnea associated with activities of daily living. Once the software package is implemented and tested, site licenses for acquiring the program will be sold to clinics, hospitals, and pharmaceutical companies worldwide. The computer assessment instruments developed in this project will quantify the patient-reported outcomes of lung disease. The overall goal is to further our understanding about these diseases and to identify better clinical outcome measures.
描述(由申请人提供): 对于呼吸系统疾病患者,呼吸困难(呼吸困难)症状是就医的最常见原因。目前测量呼吸困难对日常生活活动影响的方法依赖于医疗保健提供者进行的面对面访谈。两种常见的衡量标准是基线呼吸困难指数,代表单个时间点呼吸困难的严重程度,以及过渡性呼吸困难指数,代表呼吸困难与治疗前基线水平相比的变化。尽管这些措施被广泛接受,但访谈技术在三个方面受到批评:(1)呼吸困难严重程度的选择是由访谈者而不是患者做出的,因此会增加测量误差(2)该方法不能一致地应用在不同的医疗中心,因为并非所有测试点都雇用相同的访谈员 (3) 由于培训和雇用医疗保健提供者进行访谈并将数据输入计算机的成本,该过程非常昂贵。需要一种更便宜、标准化的方法来测量呼吸困难,并且可以在全世界范围内一致应用。在该项目的第一阶段,开发了基线呼吸困难指数和过渡性呼吸困难指数的计算机化版本,并通过与访谈版本进行比较来测试并行有效性,并通过与肺功能测试进行比较来测试构建有效性。第二阶段的目的是确定标准化方法的进一步心理测量和临床特性:基线和过渡性呼吸困难指数的测试-重测可靠性、反应性以及过渡性呼吸困难指数的最小重要临床差异。采用新的标准化计算机方法的受试者将是 126 名被诊断患有慢性肺病的患者。拟议的商业应用。允许患者评估与日常生活活动相关的呼吸困难程度的计算机软件具有良好的商业前景。一旦软件包被实施和测试,获取该程序的站点许可证将出售给世界各地的诊所、医院和制药公司。该项目开发的计算机评估工具将量化患者报告的肺病结果。总体目标是加深我们对这些疾病的了解并确定更好的临床结果指标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN C BAIRD其他文献
JOHN C BAIRD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN C BAIRD', 18)}}的其他基金
Children's Computer Assessment of Pain and Mood
儿童疼痛和情绪的计算机评估
- 批准号:
7896624 - 财政年份:2006
- 资助金额:
$ 46.05万 - 项目类别:
Assessment of Quality of Life by Patients in Pain
疼痛患者的生活质量评估
- 批准号:
6790577 - 财政年份:2001
- 资助金额:
$ 46.05万 - 项目类别:
相似国自然基金
基于EQ-5D量表的中国慢性阻塞性肺疾病患者健康效用测量工具开发与应用研究
- 批准号:72374127
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
基于睡眠期间血氧饱和度探讨室内超细颗粒物短期暴露与慢性阻塞性肺疾病患者心肺健康的关联及其机制
- 批准号:22376005
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于二萜sphaeropsidin A的Keap1/Nrf2信号通路激活剂的设计合成及抗慢性阻塞性肺疾病作用研究
- 批准号:22377066
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于蛋白乳酸化修饰探讨玉屏风散改善慢性阻塞性肺疾病急性加重中巨噬细胞极化的机制研究
- 批准号:82374304
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于唾液酸化修饰探讨黄芪-白术组分药对抑制慢性阻塞性肺疾病支气管上皮细胞衰老相关分泌表型的机制
- 批准号:82374379
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
相似海外基金
Nitrite Supplementation to Mitigate Fatigability and Increase Function in Long COVID Patients
补充亚硝酸盐可减轻长期新冠患者的疲劳并增强功能
- 批准号:
10590380 - 财政年份:2023
- 资助金额:
$ 46.05万 - 项目类别:
Using Machine Learning and Patient-Reported Outcomes to Identify Unnecessary Hospitalizations
使用机器学习和患者报告的结果来识别不必要的住院治疗
- 批准号:
10509614 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
Using Machine Learning and Patient-Reported Outcomes to Identify Unnecessary Hospitalizations
使用机器学习和患者报告的结果来识别不必要的住院治疗
- 批准号:
10696203 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
Using Machine Learning and Patient-Reported Outcomes to Identify Unnecessary Hospitalizations
使用机器学习和患者报告的结果来识别不必要的住院治疗
- 批准号:
10696203 - 财政年份:2022
- 资助金额:
$ 46.05万 - 项目类别:
Improving Diagnostic Accuracy for Acute Heart Failure
提高急性心力衰竭的诊断准确性
- 批准号:
10617357 - 财政年份:2021
- 资助金额:
$ 46.05万 - 项目类别: